NCT06577883 Next Generation Chest X-Ray Tomosynthesis for Screening of Lung Cancer
| NCT ID | NCT06577883 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Diego |
| Condition | Lung Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2023-11-02 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2023-11-02 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational clinical trial is to learn if chest tomosynthesis is a potential alternative to computed tomography for the detection of lung cancer. It will also develop artificial intelligence tools to aid in the diagnosis of lung cancer on chest tomosynthesis images. The main questions it aims to answer are: * What is the accuracy of chest X-ray tomosynthesis in diagnosing lung cancer in a population of individuals undergoing lung cancer screening or evaluation of a suspicious lung nodule? * Can artificial intelligence help us detect lung cancer on chest tomosynthesis images? Researchers will compare chest tomosynthesis images to computed tomography scans for each participant to see how they compare in diagnosing lung cancer. Participants will a chest tomosynthesis scan in addition to their routine clinical computed tomography scan.
Eligibility Criteria
Inclusion Criteria: * undergoing lung cancer screening * undergoing evaluation of suspicious pulmonary nodule * newly diagnosed lung cancer Exclusion Criteria: * prior history of lung cancer treatment
Contact & Investigator
Albert Hsiao, MD PhD
PRINCIPAL INVESTIGATOR
UC San Diego, Department of Radiology
Frequently Asked Questions
Who can join the NCT06577883 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, up to 85 Years, studying Lung Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06577883 currently recruiting?
Yes, NCT06577883 is actively recruiting participants. Contact the research team at aidaresearch2023@gmail.com for enrollment information.
Where is the NCT06577883 trial being conducted?
This trial is being conducted at San Diego, United States.
Who is sponsoring the NCT06577883 clinical trial?
NCT06577883 is sponsored by University of California, San Diego. The principal investigator is Albert Hsiao, MD PhD at UC San Diego, Department of Radiology. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.